Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Nursing Studies|March 12, 2010
Child growth from birth to 18 months old born after assisted reproductive technology--results of a national birth cohort studyShu-Hsin Lee, Ming-Yung Lee, Tung-Liang Chiang, et al.
Taiwanese Journal of Obstetrics & Gynecology|November 19, 2021
High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patientsWan-Ru Chao, Yi-Ju Lee, Ming-Yung Lee, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 30, 2018
Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-Comparison, Sham Device-Controlled TrialSabrina Mai-Yi Fan, Yu-Pin Cheng, Ming-Yung Lee, et al.
Taiwanese Journal of Obstetrics & Gynecology|September 11, 2025
HER2 mutation profiling in mucinous ovarian carcinoma: Inferences for Enhertu (trastuzumab deruxtecan) as a potential therapeutic approachHuang-Pin Shen, Ming-Yung Lee, Wan-Ru Chao, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 30, 2024
HER2 mutations in advanced cervical neuroendocrine carcinoma: implications for trastuzumab deruxtecan therapyWan-Ru Chao, Ming-Yung Lee, Gwo-Tarng Sheu, et al.
Disability and Rehabilitation|July 29, 2010
A hierarchical categorisation of tasks in mobility disabilityHui-Ya Chen, Ching-Yi Wang, Ming-Yung Lee, et al.
Clinical Pediatrics|August 19, 2003
The influence of pacifier sucking on mesenteric blood flow in infantsChing-Feng Huang, Ming-Chih Tsai, Chia-Hsiang Chu, et al.
The American Journal of Surgical Pathology|August 19, 2014
Assessing the HER2 status in mucinous epithelial ovarian cancer on the basis of the 2013 ASCO/CAP guideline updateWan-Ru Chao, Ming-Yung Lee, Wea-Lung Lin, et al.
Pageof 6